John Wiley & Sons Inc. Common Stock (WLY)

FairStock Score: 68/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for durable franchises bought at sensible prices. Wiley has a real niche in authoritative scientific, technical, medical and scholarly content, which can create subscription renewal and switching costs. But publishing is exposed to open access and technology shifts. The financial record is mixed. In fiscal 2026 ended 2026-04-30, revenue was $1.7B, net income $221.6M and diluted EPS $4.16, a large recovery from the fiscal 2024 ended 2024-04-30 loss of $200.3M. Yet the latest fiscal Q1 2027 ended 2026-07-31 showed revenue of $386.4M and a net loss of $11.7M, or diluted EPS -$0.23, versus net income of $11.7M in fiscal Q1 2026. That swing says the turnaround is not smooth. FairStock calculations at the $52.58 close on 2026-10-13 show a P/E of 14.17, P/B of 3.15, ROE of 25.91% and ROCE of only 6.25%. The high ROE leans on a D/E of 1.73. Free cash flow of $207.7M and a 7.8% FCF yield are real supports, as is a 2.96% dividend yield and beta of 0.77. However, the Graham Number is $36.22, a margin of safety of -45.17%; Piotroski is 2/9 and Altman Z is 1.51. EV/EBITDA is 10.40. FairStock's 68/100 and Lynch TURNAROUND tag fit. I would want steady revenue and less debt before calling this a classic value bargain.

In plain English: John Wiley & Sons publishes scientific journals and learning materials. The business has solid cash flow and a dividend, but profits are uneven and it carries a meaningful amount of debt. At the recent price of $52.58, the shares look more expensive than the company’s earnings and accounting value alone would suggest.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2027 10-Q (period ended 2026-07-31) · fiscal Q3 2026 10-Q (period ended 2026-01-31) · fiscal Q2 2026 10-Q (period ended 2025-10-31) · fiscal Q1 2026 10-Q (period ended 2025-07-31) · FY2026 10-K (period ended 2026-04-30) · FY2025 10-K (period ended 2025-04-30) · FY2024 10-K (period ended 2024-04-30)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer